Brian D Kavanagh

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review
    Arya Amini
    Department of Radiation Oncology, The University of Colorado School of Medicine, 1665 Aurora Court, Room 1032, Aurora, CO 80045, USA
    Radiat Oncol 9:210. 2014
  2. pmc Hypofractionated external-beam radiotherapy for prostate cancer
    L Chinsoo Cho
    University of Minnesota Medical Center, 420 Delaware Street SE, MMC 494, Minneapolis, MN 55455, USA
    Prostate Cancer 2013:103547. 2013
  3. doi request reprint Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation
    Brian D Kavanagh
    University of Colorado School of Medicine, Aurora, CO 80045, USA
    Cancer J 17:177-81. 2011
  4. doi request reprint Radiation dose-volume effects in the stomach and small bowel
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 76:S101-7. 2010
  5. doi request reprint The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colo, USA
    Front Radiat Ther Oncol 43:370-81. 2011
  6. doi request reprint Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas
    Emma C Fields
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 82:51-7. 2012
  7. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1579-84. 2009
  8. doi request reprint Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme
    Krishna Reddy
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 84:655-60. 2012
  9. doi request reprint Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme
    Changhu Chen
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 81:1066-74. 2011
  10. pmc Radiation-associated liver injury
    Charlie C Pan
    Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109 5010, USA
    Int J Radiat Oncol Biol Phys 76:S94-100. 2010

Detail Information

Publications69

  1. pmc Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review
    Arya Amini
    Department of Radiation Oncology, The University of Colorado School of Medicine, 1665 Aurora Court, Room 1032, Aurora, CO 80045, USA
    Radiat Oncol 9:210. 2014
    ..Currently, based on these published reports, re-irradiation with SBRT appears feasible for in-field thoracic recurrences, though caution must be taken in all cases of retreatment. ..
  2. pmc Hypofractionated external-beam radiotherapy for prostate cancer
    L Chinsoo Cho
    University of Minnesota Medical Center, 420 Delaware Street SE, MMC 494, Minneapolis, MN 55455, USA
    Prostate Cancer 2013:103547. 2013
    ..The preliminary results from clinical studies indicate that abbreviated fractionation programs can result in successful treatment of localized prostate cancer without escalation of late toxicity...
  3. doi request reprint Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation
    Brian D Kavanagh
    University of Colorado School of Medicine, Aurora, CO 80045, USA
    Cancer J 17:177-81. 2011
    ..The present review presents the rationale behind and current status of hypofractionation for prostate, breast, and medically inoperable early stage lung cancer...
  4. doi request reprint Radiation dose-volume effects in the stomach and small bowel
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 76:S101-7. 2010
    ..Concurrent chemotherapy has been associated with a higher risk of acute toxicity, and a history of abdominal surgery has been associated with a higher risk of late toxicity...
  5. doi request reprint The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colo, USA
    Front Radiat Ther Oncol 43:370-81. 2011
    ....
  6. doi request reprint Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas
    Emma C Fields
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 82:51-7. 2012
    ..To determine the maximum tolerated dose (MTD) of vandetanib with fractionated stereotactic radiosurgery (SRS) in patients with recurrent malignant gliomas...
  7. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1579-84. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three lung metastases...
  8. doi request reprint Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme
    Krishna Reddy
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 84:655-60. 2012
    ..To report toxicity and overall survival (OS) in patients with newly diagnosed glioblastoma multiforme (GBM) treated with hypofractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent and adjuvant temozolomide (TMZ)...
  9. doi request reprint Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme
    Changhu Chen
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 81:1066-74. 2011
    ..To determine the maximal tolerated biologic dose intensification of radiotherapy using fractional dose escalation with temozolomide (TMZ) chemotherapy in patients with newly diagnosed glioblastoma multiforme...
  10. pmc Radiation-associated liver injury
    Charlie C Pan
    Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109 5010, USA
    Int J Radiat Oncol Biol Phys 76:S94-100. 2010
    ..This article describes the endpoints, time-course, and dose-volume effect of radiation on the liver...
  11. doi request reprint Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 81:211-7. 2011
    ..To analyze the pathology, outcomes, and prognostic factors in patients with high-grade glioma undergoing reoperation after radiotherapy (RT)...
  12. doi request reprint Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas
    Amanda L Schwer
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 73:1352-7. 2009
    ..To describe the radiographic and histopathologic changes after stereotactic radiosurgery (SRS) and epidermal growth factor receptor inhibition in patients with recurrent malignant gliomas...
  13. doi request reprint Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide
    Krishna Reddy
    Departments of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045 0508, USA
    J Neurooncol 114:111-6. 2013
    ..Significant worsening was observed in cognitive functioning, social functioning, appetite loss and communication deficit. 60 Gy hypo-IMRT in 6-Gy fractions with TMZ does not appear to negatively impact overall HRQOL...
  14. ncbi request reprint Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80010 0510, USA
    Semin Radiat Oncol 12:260-71. 2002
    ....
  15. doi request reprint Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases
    Christopher C Howells
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 84:e441-6. 2012
    ..To evaluate the temporal dose response of normal liver tissue for patients with liver metastases treated with stereotactic body radiation therapy (SBRT)...
  16. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases...
  17. doi request reprint Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Douglas E Ney
    Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA
    J Neurooncol 122:135-43. 2015
    ..Bevacizumab did not prevent radiation necrosis associated with this hypofractionated radiation regimen and large PTV volumes may have contributed to high rates of presumed radiation necrosis...
  18. ncbi request reprint Stereotactic body radiation therapy in multiple organ sites
    Robert D Timmerman
    Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9183, USA
    J Clin Oncol 25:947-52. 2007
    ..Stereotactic body radiation therapy (SBRT) uses advanced technology to deliver a potent ablative dose to deep-seated tumors in the lung, liver, spine, pancreas, kidney, and prostate...
  19. doi request reprint High-dose MVCT image guidance for stereotactic body radiation therapy
    David C Westerly
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA
    Med Phys 39:4812-9. 2012
    ..The goal of this work was to investigate the use of increased imaging doses on a clinical tomotherapy machine to improve image quality for SBRT image guidance...
  20. ncbi request reprint Interim analysis of a prospective phase I/II trial of SBRT for liver metastases
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado, Aurora, Colorado 80045, USA
    Acta Oncol 45:848-55. 2006
    ..This interim analysis indicates that a very high rate of durable in-field tumor control can be safely achieved with SBRT to 1-3 liver lesions as administered in this protocol, to a prescription dose of 60 Gy in 3 fractions...
  21. ncbi request reprint The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado, Aurora, Colorado, USA
    J Appl Clin Med Phys 7:58-63. 2006
    ..In reports of SBRT, it will be helpful to maintain clear communication about the type of IC used to avoid future uncertainties about true normal tissue tolerance and tumor dose-response relationships...
  22. doi request reprint Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Denver, USA
    Acta Oncol 48:578-83. 2009
    ..We evaluate the POF in this setting to estimate the potential value of consolidative stereotactic body radiation therapy (SBRT)...
  23. ncbi request reprint Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status
    Arya Amini
    Department of Radiation Oncology Department of Biostatistics and Bioinformatics Shared Resource Department of Internal Medicine, Medical Oncology, University of Colorado Denver Department of Obstetrics and Gynecology, Divisions of Gynecologic Oncology, University of Colorado School of Medicine, Aurora, CO Northwestern University School of Law, Chicago, IL Finance and Bankruptcy, Sheppard Mullin Richter and Hampton LLP, Los Angeles, CA
    Am J Clin Oncol . 2016
    ..The purpose of this study was to evaluate whether insurance status predicts for perioperative mortality (death within 30 d of cancer-directed surgery) for the 20 most common surgically treated cancers...
  24. doi request reprint Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis
    Chad G Rusthoven
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora
    JAMA Neurol 73:821-8. 2016
    ..Following maximal safe resection or biopsy, accepted treatment paradigms for elderly patients with GBM include combined-modality therapy (CMT) with both radiotherapy (RT) and chemotherapy (CT), RT alone, and CT alone...
  25. doi request reprint Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials
    Julie A Carlson
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, USA
    J Neurooncol 123:251-7. 2015
    ..3 months for both trials. The addition of BEV to TMZ and hypo-IMRT did not improve OS for patients with GBM in two phase II trials with small patient numbers; PFS was longer with BEV, but the difference was not statistically significant...
  26. doi request reprint Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments
    Quentin Diot
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 89:626-32. 2014
    ..To quantitatively assess changes in computed tomography (CT)-defined normal lung tissue density after conventional and hypofractionated radiation therapy (RT)...
  27. pmc Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib
    Gregory N Gan
    Department of Radiation Oncology, University of Colorado, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 88:892-8. 2014
    ..To analyze the durability and toxicity of radiotherapeutic local ablative therapy (LAT) applied to extra-central nervous system (eCNS) disease progression in anaplastic lymphoma kinase-positive non-small cell lung cancer (NSCLC) patients...
  28. ncbi request reprint The North American experience with stereotactic body radiation therapy in non-small cell lung cancer
    Robert D Timmerman
    Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9183, USA
    J Thorac Oncol 2:S101-12. 2007
    ..In North America, the majority of prospective investigation using stereotactic body radiation therapy (SBRT) for thoracic targets has been carried out treating medically inoperable patients with non-small cell lung cancer...
  29. ncbi request reprint Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience
    Douglas W Arthur
    Department of Radiation Oncology, Virginia Commonwealth University Medical College of Virginia Campus, Richmond, VA, USA
    Int J Radiat Oncol Biol Phys 56:681-9. 2003
    ..In a cohort of patients who received low-dose-rate (LDR) or high-dose-rate (HDR) PBB after lumpectomy, the clinical characteristics and treatment parameters were analyzed to identify predictors for an unfavorable cosmetic outcome...
  30. ncbi request reprint A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas
    Amanda L Schwer
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80045 0508, USA
    Int J Radiat Oncol Biol Phys 70:993-1001. 2008
    ..To determine the maximum tolerated dose (MTD) of fractionated stereotactic radiosurgery (SRS) with gefitinib in patients with recurrent malignant gliomas...
  31. doi request reprint Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base
    Arya Amini
    Department of Radiation Oncology and Division of Urology, Department of Surgery PM, University of Colorado School of Medicine, Aurora, Colorado
    J Urol 195:1453-8. 2016
    ..We evaluated survival outcomes between dose-escalated EBRT (external beam radiotherapy) vs EBRT plus brachytherapy for intermediate and high risk prostate cancer using NCDB (National Cancer Data Base)...
  32. pmc Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
    Arya Amini
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado
    Pract Radiat Oncol 5:e589-96. 2015
    ....
  33. doi request reprint The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population
    Chad G Rusthoven
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 90:894-902. 2014
    ....
  34. doi request reprint The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study
    Chad G Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 88:1064-73. 2014
    ....
  35. doi request reprint Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base
    Arya Amini
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO Electronic address
    Urol Oncol 34:165.e1-9. 2016
    ..This study׳s objective was to evaluate the survival benefit of adding ADT to high-dose RT for patients with intermediate-risk prostate cancer using the National Cancer Data Base...
  36. pmc Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data
    Douglas Brennan
    University of Colorado School of Medicine, Aurora, Colorado
    Int J Radiat Oncol Biol Phys 92:423-9. 2015
    ..Pulmonary function tests (PFTs) provide a clinically established way of evaluating lung function. The purpose of our work was to perform a clinical validation by comparing 4DCT-ventilation metrics with PFT data...
  37. doi request reprint Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer
    Chad G Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO Electronic address
    Urol Oncol 33:71.e11-9. 2015
    ..In this analysis, outcomes for biopsy-assigned GS 6 to 10 were comprehensively evaluated to identify stratifications prognostic for survival in patients undergoing external beam radiation therapy (EBRT)...
  38. doi request reprint The prognostic significance of Gleason scores in metastatic prostate cancer
    Chad G Rusthoven
    Department of Radiation Oncology, University of Colorado Denver, Aurora, CO Electronic address
    Urol Oncol 32:707-13. 2014
    ..8. In this analysis, we comprehensively evaluate the GS as a prognostic factor for mPCa in the era of the updated Gleason grading system...
  39. doi request reprint Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases
    Michelle A Stinauer
    Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado, USA
    Int J Radiat Oncol Biol Phys 83:e613-8. 2012
    ..To characterize changes in standardized uptake value (SUV) in positron emission tomography (PET) scans and determine the pace of normal tissue regeneration after stereotactic body radiation therapy (SBRT) for solid tumor liver metastases...
  40. ncbi request reprint Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, 1665 North Ursula Street, Aurora, CO 80045, USA
    Hematol Oncol Clin North Am 20:87-95. 2006
    ..It will be especially interesting to investigate how SRS and SBRT might best be combined with new molecularly targeted systemic agents as the field of oncology progresses through the twenty-first century...
  41. ncbi request reprint Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis
    Joseph M Baisden
    Department of Radiation Oncology, Medical School, University of Virginia Health System, Charlottesville, VA 22908, USA
    Int J Radiat Oncol Biol Phys 66:620-5. 2006
    ..We hypothesized that the maximum tolerable dose (MTD) delivered to a lesion by Helical TomoTherapy-based SBRT could be predicted based on the planning target volume (PTV) and liver volume...
  42. ncbi request reprint Lung cancer: a model for implementing stereotactic body radiation therapy into practice
    Robert Timmerman
    Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9183, USA
    Front Radiat Ther Oncol 40:368-85. 2007
    ..While mechanisms of this injury remain elusive, ongoing prospective trials offer the hope of finding the ideal application for SBRT in treating pulmonary targets...
  43. ncbi request reprint The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation
    Kerry W Eley
    Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University, Richmond, VA 23298 0058, USA
    Int J Radiat Oncol Biol Phys 54:542-50. 2002
    ....
  44. ncbi request reprint Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Aurora, CO, USA
    Semin Radiat Oncol 16:77-84. 2006
    ..With proper conduct though, SBRT can be an extremely effective treatment option for oligometastases...
  45. doi request reprint Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
    Chad G Rusthoven
    Chad G Rusthoven, Bernard L Jones, Thomas W Flaig, E David Crawford, Brian D Kavanagh, and Thomas J Pugh, University of Colorado School of Medicine, Aurora, CO Matthew Koshy, University of Illinois at Chicago School of Medicine Matthew Koshy, The University of Chicago School of Medicine, Chicago, IL David J Sher, University of Texas Southwestern, Dallas Usama Mahmood and Brian F Chapin University of Texas, MD Anderson Cancer Center, Houston, TX and Ronald C Chen University of North Carolina at Chapel Hill, Chapel Hill, NC
    J Clin Oncol 34:2835-42. 2016
    ..We used the National Cancer Database (NCDB) to evaluate the overall survival (OS) of men with mPCa treated with androgen deprivation (ADT) with and without prostate RT...
  46. doi request reprint Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base
    Arya Amini
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO Electronic address
    Brachytherapy 15:136-46. 2016
    ..The purpose was to evaluate survival outcomes between external beam radiotherapy (EBRT) plus brachytherapy and brachytherapy alone for intermediate-risk prostate cancer, using the National Cancer Data Base...
  47. pmc Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation study
    Yevgeniy Vinogradskiy
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 89:199-205. 2014
    ..The purpose of this work was to compare 4DCT-ventilation to nuclear medicine ventilation, using clinically relevant global metrics and radiologist observations...
  48. doi request reprint Radiation therapy for liver metastases
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Semin Radiat Oncol 21:264-70. 2011
    ..There is growing evidence that strategies using aggressive or ablative local therapies as an adjunct to systemic therapy might achieve improvements in overall outcome as long as they are administered safely...
  49. pmc Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
    Michelle A Stinauer
    University of Colorado Denver, School of Medicine, Aurora, Colorado, USA
    Radiat Oncol 6:34. 2011
    ..Whereas stereotactic body radiation therapy (SBRT) involves radiation dose intensification via escalation, we hypothesize SBRT might result in similar high local control rates as previously published on metastases of varying histologies...
  50. doi request reprint Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis
    Daniel T Chang
    Department of Radiation Oncology, Stanford University, Stanford, California, USA
    Cancer 117:4060-9. 2011
    ..This study was undertaken to determine outcomes of stereotactic body radiotherapy for colorectal liver metastases in a pooled patient cohort...
  51. ncbi request reprint A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80045 0510, USA
    Int J Radiat Oncol Biol Phys 62:1371-8. 2005
    ..To determine the maximum tolerated dose (MTD) of stereotactic body radiation therapy (SBRT) for liver metastases...
  52. doi request reprint Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base
    Arya Amini
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado
    Int J Radiat Oncol Biol Phys 93:1052-63. 2015
    ..The purpose of our study was to evaluate the survival benefit of adding WPRT versus PO-RT for high-risk, node-negative prostate cancer, using the National Cancer Data Base (NCDB)...
  53. doi request reprint Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme
    Krishna Reddy
    Department of Radiation Oncology, University of Toledo School of Medicine, Toledo, Ohio, USA
    J Med Imaging Radiat Oncol 58:714-21. 2014
    ....
  54. pmc Hepatic radiation toxicity: avoidance and amelioration
    Chandan Guha
    Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA
    Semin Radiat Oncol 21:256-63. 2011
    ..Also, in the clinical setting of veno-occlusive liver disease after high-dose chemotherapy, agents with fibrinolytic and antithrombotic properties can reverse liver failure, suggesting a possible role in the setting of RILD...
  55. ncbi request reprint The promise of stereotactic body radiation therapy in a new era of oncology
    Brian D Kavanagh
    University of Colorado Comprehensive Cancer Center, Aurora, CO, USA
    Front Radiat Ther Oncol 40:340-51. 2007
    ..Here, the history of SBRT is briefly reviewed, and a projection of the anticipated role of SBRT within the context of multimodality cancer treatment regimens of the future is presented...
  56. doi request reprint High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials
    Kyle E Rusthoven
    Department of Radiation Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045 0508, USA
    Clin Lung Cancer 9:106-11. 2008
    ..Because patients with early-stage bladder transitional cell carcinoma (TCC) often have a long survival, we considered whether they would constitute a suitable population for a screening study...
  57. ncbi request reprint Stereotactic body radiation therapy
    Robert D Timmerman
    Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Curr Probl Cancer 29:120-57. 2005
  58. pmc Improved survival with the addition of radiotherapy to androgen deprivation: questions answered and a review of current controversies in radiotherapy for non-metastatic prostate cancer
    Arya Amini
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Ann Transl Med 4:14. 2016
    ....
  59. doi request reprint Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer
    Puneeth Iyengar
    Puneeth Iyengar, Zabi Wardak, Irma Smith, Chul Ahn, David E Gerber, Jonathan Dowell, Randall Hughes, Ramzi Abdulrahman, Hak Choy, Robert Timmerman, University of Texas Southwestern Medical Center, Dallas, TX Brian D Kavanagh, D Ross Camidge, Laurie E Gaspar, Robert C Doebele, and Paul A Bunn, University of Colorado School of Medicine, Aurora, CO
    J Clin Oncol 32:3824-30. 2014
    ..Cytoreduction with stereotactic body radiation therapy (SBRT) may help systemic agents delay relapse...
  60. ncbi request reprint A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Denver, CO, USA
    Int J Radiat Oncol Biol Phys 53:172-9. 2002
    ..To develop a theoretical model for oxygen delivery to tumors, and to use the model to simulate the effects of changing the affinity of hemoglobin for oxygen on tumor oxygenation...
  61. ncbi request reprint Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora 80010 0510, USA
    Med Dosim 27:177-84. 2002
    ..This is especially relevant to the possible introduction of intrafractional movement and resulting inaccuracy, as well as facility efficiency...
  62. ncbi request reprint The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy
    E David Crawford
    Department of Urologic Oncology, University of Colorado Health Sciences Center, Aurora, CO 80010, USA
    Am J Clin Oncol 29:517-23. 2006
    ..This review will analyze the current state of knowledge of LUTS secondary to RT for prostate cancer and review treatment options for this complication...
  63. ncbi request reprint Liver, renal, and retroperitoneal tumors: stereotactic radiotherapy
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Aurora, CO 80045, USA
    Front Radiat Ther Oncol 40:415-26. 2007
    ....
  64. doi request reprint Stereotactic body radiation therapy: a new paradigm in radiotherapy management of cancer
    Timothy D Solberg
    Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    J Am Coll Radiol 5:673-7. 2008
  65. doi request reprint Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuli
    Lian Zhang
    Department of Pharmacology, University of Colorado, School of Medicine, Aurora, CO, USA
    Clin Cancer Res 16:4478-89. 2010
    ....
  66. doi request reprint Motion management and image guidance for thoracic tumor radiotherapy: clinical treatment programs
    Billy W Loo
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, Calif, USA
    Front Radiat Ther Oncol 43:271-91. 2011
    ..This discussion will present practical solutions for motion management and image guidance of radiotherapy for thoracic tumors, and most of these concepts are widely applicable to treatment of other tumor sites as well...
  67. pmc Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)
    Basel Altoos
    Department of Radiation Oncology, University of Colorado School of Medicine, 1665 Aurora Court, Room 1032, Aurora, CO, 80045, USA
    Radiat Oncol 10:218. 2015
    ..We report the radiographic response rate of SBRT compared to conventional fractionated radiotherapy (CF-EBRT) for thoracic, abdominal, skin and soft tissue RCC lesions treated at our institution...
  68. ncbi request reprint Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors
    Sheri A Poznanovic
    Department of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, 4200 E 9th Avenue, Box B 205, Denver, CO 80262, USA
    Otolaryngol Head Neck Surg 134:437-42. 2006
    ..This study evaluates acute toxicity and short-term efficacy of single-fraction stereotactic radiosurgery (SRS) for the treatment of GJT...
  69. ncbi request reprint The effect of high-dose-rate brachytherapy dwell sequence on cell survival
    Mark R Arnfield
    Department of Radiation Oncology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298, USA
    Int J Radiat Oncol Biol Phys 52:850-7. 2002
    ..We investigated the possible effects of the sequence in which dose is delivered at two different dose rates, representative of dose rates that occur during an HDR treatment...